share_log

擬根據一般性授權發行3,500,000,000美元0.875%於2029年到期的可轉換債券

Proposed Issue of U.S.$3,500,000,000 0.875% Convertible Bonds Due 2029 under General Mandate

HKEX ·  Jul 16 06:57
Summary by Futu AI
中國平安於2024年7月15日宣布，將發行總額為3,500,000,000美元、年利率0.875%、於2029年到期的可轉換債券。該債券將由摩根士丹利、J.P. Morgan及中國平安證券（香港）有限公司共同擔任聯席全球協調人、聯席賬簿管理人及聯席牽頭經辦人。債券將可轉換為約625,203,614股H股，轉換價為每股43.71港元，假設全部轉換，將佔公司現有已發行H股數目的8.39%。公司計劃使用所得款項淨額用於金融業務發展、醫療及養老新戰略業務需求及一般公司用途。債券及轉換股份將申請在香港聯交所上市。此次發行將不會在美國境內進行，並已獲國家發改委核發《企業借用外債審核登記證明》。債券發行及認購將待達成及╱或豁免認購協議所載若干先決條件後完成，且認購協議在若干情況下可終止。
中國平安於2024年7月15日宣布，將發行總額為3,500,000,000美元、年利率0.875%、於2029年到期的可轉換債券。該債券將由摩根士丹利、J.P. Morgan及中國平安證券（香港）有限公司共同擔任聯席全球協調人、聯席賬簿管理人及聯席牽頭經辦人。債券將可轉換為約625,203,614股H股，轉換價為每股43.71港元，假設全部轉換，將佔公司現有已發行H股數目的8.39%。公司計劃使用所得款項淨額用於金融業務發展、醫療及養老新戰略業務需求及一般公司用途。債券及轉換股份將申請在香港聯交所上市。此次發行將不會在美國境內進行，並已獲國家發改委核發《企業借用外債審核登記證明》。債券發行及認購將待達成及╱或豁免認購協議所載若干先決條件後完成，且認購協議在若干情況下可終止。
On July 15, 2024, Ping An Insurance announced that it will issue $3.5 billion convertible bonds with an annual interest rate of 0.875% due in 2029. The bonds will be jointly coordinated by Morgan Stanley, J.P. Morgan, and Ping An Securities (Hong Kong) Limited as joint global coordinators, joint bookrunners, and joint lead managers. The bonds will be convertible into approximately 625,203,614 H shares at a conversion price of HKD 43.71 per share. Assuming full conversion, this will account for 8.39% of the company's existing issued H shares. The company plans to use the net proceeds for financial business development, medical and retirement new strategic business requirements, and general corporate purposes. The bonds and convertible shares will be listed on the Hong Kong Stock Exchange. The...Show More
On July 15, 2024, Ping An Insurance announced that it will issue $3.5 billion convertible bonds with an annual interest rate of 0.875% due in 2029. The bonds will be jointly coordinated by Morgan Stanley, J.P. Morgan, and Ping An Securities (Hong Kong) Limited as joint global coordinators, joint bookrunners, and joint lead managers. The bonds will be convertible into approximately 625,203,614 H shares at a conversion price of HKD 43.71 per share. Assuming full conversion, this will account for 8.39% of the company's existing issued H shares. The company plans to use the net proceeds for financial business development, medical and retirement new strategic business requirements, and general corporate purposes. The bonds and convertible shares will be listed on the Hong Kong Stock Exchange. The issuance will not be conducted in the United States and has obtained the Enterprise Borrowing Overseas Debt Examination and Registration Certificate issued by the National Development and Reform Commission. The issuance and subscription of bonds will be completed after the fulfillment and/or exemption of certain precedent conditions stipulated in the subscription agreement, and the subscription agreement may be terminated under certain circumstances.

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.